Nobuyoshi Shimizu,Atsushi Takayanagi,Tetsuhiko Yoshida
申请号：
US13701947
公开号：
US20130142812A1
申请日:
2011.06.03
申请国别(地区):
US
年份:
2013
代理人:
摘要：
A cell growth inhibitor that includes, as an antibody component, an artificially produced anti-EGFR antibody having specific binding capacity to EGFR which is characterized in that an epitope therefor is in a cysteine-rich subdomain 2 (C2 domain) and/or in a ligand-binding domain 1 (L1 domain) among four subdomains contained in the extracellular domain of EGFR.
